ArticleJournal of clinical microbiology2007
Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis.
Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 66 citations in OpenAlex.
- Molecular identification and diagnostic challenges ofIranian journal of microbiology · 2025Article
- Successful Treatment ofInfection and drug resistance · 2025Article
- Emerging pathogens: the underestimated risk ofFrontiers in microbiology · 2025Article
- First Report of the Emerging PathogenJournal of fungi (Basel, Switzerland) · 2024Article
- A Case Report of Urinary Tract Infection and Fungemia Due toInfection and drug resistance · 2024Article
- Gut-derived fungemia due to Kodamaea ohmeri combined with invasive pulmonary aspergillosis: a case report.BMC infectious diseases · 2022Article
- Answer to February 2022 Photo Quiz.Journal of clinical microbiology · 2022Article
- Review
- RareBMJ case reports · 2019Article
- Molecular identification and antifungal susceptibility pattern ofCurrent medical mycology · 2019Article
- Identification and antifungal susceptibility profiles ofInfection and drug resistance · 2019Article
- Article
- Fungemia due to Kodamaea ohmeri in a young infant and review of the literature.Medical mycology case reports · 2016Article
- Kodameae ohmeri - An Emerging Yeast: Two Cases and Literature Review.Journal of clinical and diagnostic research : JCDR · 2015Article
- Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).Lasers in medical science · 2012Article
- Echinocandin resistance in two Candida haemulonii isolates from pediatric patients.Journal of clinical microbiology · 2012Article
- First case report of bloodstream infection due to a Candida species closely related to the novel species Candida pseudorugosa.Journal of clinical microbiology · 2012Article
- Genetic diversity among Korean Candida albicans bloodstream isolates: assessment by multilocus sequence typing and restriction endonuclease analysis of genomic DNA by use of BssHII.Journal of clinical microbiology · 2011Article
- Kodamaea ohmeri tricuspid valve endocarditis with right ventricular inflow obstruction in a neonate with structurally normal heart.Annals of pediatric cardiology · 2011Article
- Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature.Mycopathologia · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data on clinical isolates of Kodamaea (Pichia) ohmeri, an emerging fungal pathogen, are scarce. Over the past 5 years, we identified yeast isolates from nine patients with fungemia as K. ohmeri by using the API 20C system. Here, we reanalyzed these isolates first by sequencing the internal transcribed spacer 2 (ITS2) regions and then by growing the isolates on CHROMagar Candida medium and subjecting them to pulsed-field gel electrophoresis (PFGE). Based on their ITS2 sequences, six of the nine isolates were confirmed as K. ohmeri, while the others were identified as Candida haemulonii (n = 2) and Candida parapsilosis (n = 1). PFGE karyotyping of the K. ohmeri isolates revealed similar major bands, and their colonies showed a characteristic color change from pink to blue when grown on CHROMagar Candida medium for more than 48 h. For K. ohmeri, the ranges of MICs of fluconazole, voriconazole, caspofungin, and micafungin were 2 to 32 mug/ml, 0.03 to 0.5 mug/ml, 0.125 to 0.25 mug/ml, and 0.03 to 0.06 mug/ml, respectively. Restriction endonuclease analysis of genomic NotI-digested DNA (REAG-N) from isolates from different patients produced unique patterns, suggesting that the fungemia had occurred sporadically. This study determined that ITS2 sequence data, PFGE karyotypes, and CHROMagar Candida chromogenic culture medium are reliable diagnostic tools for identifying K. ohmeri while REAG-N is useful for genotyping the clinical isolates of K. ohmeri.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.